Related references
Note: Only part of the references are listed.Comparing the performance of six human papillomavirus tests in a screening population
J. Cuzick et al.
BRITISH JOURNAL OF CANCER (2013)
Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors
Salvatore Vaccarella et al.
EUROPEAN JOURNAL OF CANCER (2013)
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
L. Stewart Massad et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
High-Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV-Proofer for Detection of Cervical High-Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA-Positive Women with Normal Cytology
D. C. Rijkaart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Mark H. Stoler et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Clinical Performance of a Human Papillomavirus Messenger RNA Test (Aptima HPV Assay) on Residual Material From Archived 3-Year-Old PreservCyt Samples With Low-Grade Squamous Intraepithelial Lesion
Marianne Waldstrom et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3
Irene T. Ovestad et al.
GYNECOLOGIC ONCOLOGY (2011)
Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study
Joseph Monsonego et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Performance of the Aptima High-Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology
Andreas Clad et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
S. Brismar-Wendel et al.
BRITISH JOURNAL OF CANCER (2009)
Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets
Damon Getman et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions
Janel Dockter et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Analytical characterization of the APTIMA® HPV Assay
Janel Dockter et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia
Kate Cuschieri et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1
J. Jordan et al.
CYTOPATHOLOGY (2008)
Routine audit of large-scale cervical cancer screening programs
Jack Cuzick
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Jack Cuzick et al.
VACCINE (2008)
CIN2 is a much less reproducible and less valid diagnosis than CIN3: Results from a histological review of population-based cervical samples
Joseph D. Carreon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Human papillomavirus type specific DNA and RNA persistence - Implications for cervical disease progression and monitoring
KS Cuschieri et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
The 2001 Bethesda System - Terminology for reporting results of cervical cytology
D Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom
DR Scott et al.
CANCER CYTOPATHOLOGY (2002)
Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996
K Hemminki et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2002)
Share Paper
